Sarah Meyer

1.1k total citations · 1 hit paper
28 papers, 755 citations indexed

About

Sarah Meyer is a scholar working on Epidemiology, Microbiology and Health. According to data from OpenAlex, Sarah Meyer has authored 28 papers receiving a total of 755 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 14 papers in Microbiology and 9 papers in Health. Recurrent topics in Sarah Meyer's work include Bacterial Infections and Vaccines (14 papers), Vaccine Coverage and Hesitancy (9 papers) and Pneumonia and Respiratory Infections (7 papers). Sarah Meyer is often cited by papers focused on Bacterial Infections and Vaccines (14 papers), Vaccine Coverage and Hesitancy (9 papers) and Pneumonia and Respiratory Infections (7 papers). Sarah Meyer collaborates with scholars based in United States, Uganda and Burkina Faso. Sarah Meyer's co-authors include David Yankey, Laurie D. Elam–Evans, Shannon Stokley, Lauri E. Markowitz, Charnetta Williams, James A. Singleton, Tanja Y. Walker, Benjamin Fredua, Robert H. Gilman and Lilia Cabrera and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and The Journal of Infectious Diseases.

In The Last Decade

Sarah Meyer

27 papers receiving 738 citations

Hit Papers

National, Regional, State, and Selected Local Area Vaccin... 2017 2026 2020 2023 2017 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah Meyer United States 12 507 218 217 132 102 28 755
Rosemary McCann United Kingdom 15 560 1.1× 301 1.4× 162 0.7× 209 1.6× 26 0.3× 23 848
James H. Conway United States 13 323 0.6× 178 0.8× 161 0.7× 143 1.1× 36 0.4× 47 617
Jane Whelan Netherlands 16 475 0.9× 146 0.7× 332 1.5× 152 1.2× 49 0.5× 46 794
Steve Black United States 14 313 0.6× 129 0.6× 78 0.4× 216 1.6× 56 0.5× 27 749
Emilia Tiscione Italy 16 424 0.8× 206 0.9× 78 0.4× 153 1.2× 25 0.2× 39 561
Kimberley Simmonds Canada 16 458 0.9× 185 0.8× 124 0.6× 244 1.8× 39 0.4× 48 720
Catherine Weil-Olivier France 16 711 1.4× 237 1.1× 175 0.8× 176 1.3× 73 0.7× 45 867
Tinne Lernout Belgium 18 387 0.8× 199 0.9× 127 0.6× 375 2.8× 199 2.0× 53 904
Vladimir Gîlca Canada 26 1.2k 2.3× 584 2.7× 153 0.7× 454 3.4× 22 0.2× 73 1.6k
Gaby Smits Netherlands 18 522 1.0× 269 1.2× 76 0.4× 279 2.1× 42 0.4× 38 860

Countries citing papers authored by Sarah Meyer

Since Specialization
Citations

This map shows the geographic impact of Sarah Meyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Meyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Meyer more than expected).

Fields of papers citing papers by Sarah Meyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Meyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Meyer. The network helps show where Sarah Meyer may publish in the future.

Co-authorship network of co-authors of Sarah Meyer

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Meyer. A scholar is included among the top collaborators of Sarah Meyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Meyer. Sarah Meyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hills, Susan L., Elaine R. Miller, Edwin J. Asturias, et al.. (2025). Surveillance for adverse events following use of live attenuated chikungunya vaccine, United States, 2024, and the associated public health response in 2024 and 2025. Eurosurveillance. 30(32). 5 indexed citations
2.
Meaney‐Delman, Dana, Kara N.D. Polen, Tara C. Jatlaoui, et al.. (2024). Planning for the future of maternal immunization: Building on lessons learned from the COVID-19 pandemic. Vaccine. 42. 125644–125644. 3 indexed citations
3.
Jones-Jack, Nkenge, John D. Grabenstein, Abdulhakeem Abayomi Olorukooba, et al.. (2024). Pharmacists’ answer to the COVID-19 pandemic: Contribution of the Federal Retail Pharmacy Program to COVID-19 vaccination across sociodemographic characteristics—United States. Journal of the American Pharmacists Association. 65(1). 102305–102305.
4.
Stone, Nimalie D., Amy Parker Fiebelkorn, Angela Guo, et al.. (2024). Challenges and opportunities during the COVID-19 vaccination efforts in long-term care. Vaccine. 42. 125554–125554. 1 indexed citations
5.
Jones-Jack, Nkenge, Abdulhakeem Abayomi Olorukooba, Shannon Stokley, et al.. (2024). Federal Retail Pharmacy Program Contributions to Bivalent mRNA COVID-19 Vaccinations Across Sociodemographic Characteristics — United States, September 1, 2022–September 30, 2023. MMWR Morbidity and Mortality Weekly Report. 73(13). 286–290. 3 indexed citations
7.
Oliver, Sara E., Megan Wallace, Evelyn Twentyman, et al.. (2023). Development of COVID-19 vaccine policy — United States, 2020–2023. Vaccine. 42. 125512–125512. 10 indexed citations
8.
Crowe, Samuel J., et al.. (2023). Risk Factors for Serogroup B Meningococcal Disease Among College Students. Open Forum Infectious Diseases. 10(12). ofad607–ofad607. 6 indexed citations
9.
Folaranmi, Temitope, Cécilia B. Kretz, Hajime Kamiya, et al.. (2017). Increased Risk for Meningococcal Disease Among Men Who Have Sex With Men in the United States, 2012–2015. Clinical Infectious Diseases. 65(5). 756–763. 55 indexed citations
10.
Lu, Peng-Jun, David Yankey, Jenny Jeyarajah, et al.. (2017). Impact of Provider Recommendation on Tdap Vaccination of Adolescents Aged 13–17 Years. American Journal of Preventive Medicine. 53(3). 373–384. 10 indexed citations
11.
Meyer, Sarah. (2017). Revised Guidelines for the Evaluation and Public Health Management of Suspected Outbreaks of Meningococcal Disease in the United States. 2 indexed citations
12.
O’Halloran, Alissa, Peng-Jun Lu, Sarah Meyer, et al.. (2017). Tdap Vaccination Among Healthcare Personnel—21 States, 2013. American Journal of Preventive Medicine. 54(1). 119–123. 10 indexed citations
13.
Breakwell, Lucy, Melissa Whaley, Unab I. Khan, et al.. (2017). Meningococcal carriage among a university student population – United States, 2015. Vaccine. 36(1). 29–35. 35 indexed citations
14.
Rondy, Marc, et al.. (2016). Vaccine Effectiveness of Polysaccharide Vaccines Against Clinical Meningitis - Niamey, Niger, June 2015. PLoS Currents. 8. 3 indexed citations
15.
O’Halloran, Alissa, Peng-Jun Lu, Walter W. Williams, Helen Ding, & Sarah Meyer. (2016). Tetanus, diphtheria, and acellular pertussis vaccination among women of childbearing age—United States, 2013. American Journal of Infection Control. 44(7). 786–793. 10 indexed citations
16.
Whaley, Melissa, Hajime Kamiya, Jessica R. MacNeil, et al.. (2016). Meningococcal Disease Among Men Who Have Sex with Men—United States, 2012–2015. Open Forum Infectious Diseases. 3(suppl_1). 3 indexed citations
18.
Alleman, Mary, et al.. (2014). Improved Acute Flaccid Paralysis Surveillance Performance in the Democratic Republic of the Congo, 2010–2012. The Journal of Infectious Diseases. 210(suppl_1). S50–S61. 12 indexed citations
19.
Bowden, Katherine E., Margaret M. Williams, Pamela K. Cassiday, et al.. (2014). Molecular Epidemiology of the Pertussis Epidemic in Washington State in 2012. Journal of Clinical Microbiology. 52(10). 3549–3557. 52 indexed citations
20.
Meyer, Sarah, et al.. (2013). Impact of a New Method of Warfarin Management on Patient Satisfaction, Time, and Cost. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 33(11). 1147–1155. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026